Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Depth of Wound
1.1.3. Cause
1.1.4. End-use
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Depth of Wound outlook
2.2.3. Cause outlook
2.2.4. End-use outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Burn Care Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising incidence of burn injuries
3.2.1.2. High demand for skin grafts
3.2.1.3. Increasing awareness regarding treatment options
3.2.2. Market restraint analysis
3.2.2.1. High cost of burn care treatment
3.3. Burn care market analysis tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Burn Care Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Advanced dressings
4.1.2. Biologics
4.1.3. Traditional burn care products
4.1.4. Other Burn Care Products
4.2. Product Market Share, 2023 & 2030
4.3. Segment Dashboard
4.4. Global Burn Care Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Advanced dressings
4.5.1.1. Advanced dressings market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.2. Alginate dressing
4.5.1.2.1. Alginate dressing market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.3. Collagen dressing
4.5.1.3.1. Collagen dressing market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.4. Hydrogel dressing
4.5.1.4.1. Hydrogel dressing market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.5. Hydrocolloid dressing
4.5.1.5.1. Hydrocolloid dressing market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.6. Wound contact layers
4.5.1.6.1. Wound contact layers market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.7. Film dressing
4.5.1.7.1. Film dressing market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.8. Foam dressing
4.5.1.8.1. Foam dressing market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.9. Other advanced dressing
4.5.1.9.1. Other advanced dressing market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Biologics
4.5.2.1. Biologics market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. Traditional burn care
4.5.3.1. Traditional burn care market estimates and forecast 2018 to 2030 (USD Million)
4.5.4. Other burn care products
4.5.4.1. Other burn care products market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Burn care Market: Depth of Wound Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Minor burns
5.1.2. Partial thickness burns
5.1.3. Full thickness burns
5.2. Depth of Wound Market Share, 2023 & 2030
5.3. Segment Dashboard
5.4. Global Burn Care Market by Depth of Wound Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Minor burns
5.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Partial thickness burns
5.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5.3. Full thickness burns
5.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Burn care Market: Cause Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Thermal burns
6.1.2. Electrical burns
6.1.3. Radiation burns
6.1.4. Chemical burns
6.1.5. Friction Burns
6.2. Cause Market Share, 2023 & 2030
6.3. Segment Dashboard
6.4. Global Burn Care Market by Cause Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Thermal burns
6.5.1.1. Market estimates and forecast 2018 to 2030 (USD million)
6.5.2. Electrical burns
6.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.5.3. Radiation burns
6.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.5.4. Chemical burns
6.5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.5.5. Friction Burns
6.5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Burn care Market: End-use Estimates & Trend Analysis
7.1. Definitions and Scope
7.1.1. Hospitals
7.1.2. Outpatient facilities
7.1.3. Home care
7.1.4. Research & manufacturing
7.2. End-use Market Share, 2023 & 2030
7.3. Segment Dashboard
7.4. Global Burn Care Market by End-use Outlook
7.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5.1. Hospitals
7.5.1.1. Market estimates and forecast 2018 to 2030 (USD million)
7.5.2. Outpatient facilities
7.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
7.5.3. Home care
7.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
7.5.4. Research & manufacturing
7.5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 8. Burn care Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2023 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.5. North America
8.5.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
8.5.2. U.S.
8.5.2.1. Key country dynamics
8.5.2.2. Competitive scenario
8.5.2.3. Regulatory framework
8.5.2.4. Reimbursement scenario
8.5.2.5. U.S. market estimates and forecasts, 2018 – 2030
8.5.3. Canada
8.5.3.1. Key country dynamics
8.5.3.2. Competitive scenario
8.5.3.3. Regulatory framework
8.5.3.4. Reimbursement scenario
8.5.3.5. Canada market estimates and forecasts, 2018 – 2030
8.6. Europe
8.6.1. UK
8.6.1.1. Key country dynamics
8.6.1.2. Competitive scenario
8.6.1.3. Regulatory framework
8.6.1.4. Reimbursement scenario
8.6.1.5. UK market estimates and forecasts, 2018 – 2030
8.6.2. Germany
8.6.2.1. Key country dynamics
8.6.2.2. Competitive scenario
8.6.2.3. Regulatory framework
8.6.2.4. Reimbursement scenario
8.6.2.5. Germany market estimates and forecasts, 2018 – 2030
8.6.3. France
8.6.3.1. Key country dynamics
8.6.3.2. Competitive scenario
8.6.3.3. Regulatory framework
8.6.3.4. Reimbursement scenario
8.6.3.5. France market estimates and forecasts, 2018 – 2030
8.6.4. Italy
8.6.4.1. Key country dynamics
8.6.4.2. Competitive scenario
8.6.4.3. Regulatory framework
8.6.4.4. Reimbursement scenario
8.6.4.5. Italy market estimates and forecasts, 2018 – 2030
8.6.5. Spain
8.6.5.1. Key country dynamics
8.6.5.2. Competitive scenario
8.6.5.3. Regulatory framework
8.6.5.4. Reimbursement scenario
8.6.5.5. Spain market estimates and forecasts, 2018 – 2030
8.6.6. Denmark
8.6.6.1. Key country dynamics
8.6.6.2. Competitive scenario
8.6.6.3. Regulatory framework
8.6.6.4. Reimbursement scenario
8.6.6.5. Denmark market estimates and forecasts, 2018 – 2030
8.6.7. Sweden
8.6.7.1. Key country dynamics
8.6.7.2. Competitive scenario
8.6.7.3. Regulatory framework
8.6.7.4. Reimbursement scenario
8.6.7.5. Sweden market estimates and forecasts, 2018 – 2030
8.6.8. Norway
8.6.8.1. Key country dynamics
8.6.8.2. Competitive scenario
8.6.8.3. Regulatory framework
8.6.8.4. Reimbursement scenario
8.6.8.5. Norway market estimates and forecasts, 2018 – 2030
8.7. Asia Pacific
8.7.1. Japan
8.7.1.1. Key country dynamics
8.7.1.2. Competitive scenario
8.7.1.3. Regulatory framework
8.7.1.4. Reimbursement scenario
8.7.1.5. Japan market estimates and forecasts, 2018 – 2030
8.7.2. India
8.7.2.1. Key country dynamics
8.7.2.2. Competitive scenario
8.7.2.3. Regulatory framework
8.7.2.4. Reimbursement scenario
8.7.2.5. India market estimates and forecasts, 2018 – 2030
8.7.3. China
8.7.3.1. Key country dynamics
8.7.3.2. Competitive scenario
8.7.3.3. Regulatory framework
8.7.3.4. Reimbursement scenario
8.7.3.5. China market estimates and forecasts, 2018 – 2030
8.7.4. South Korea
8.7.4.1. Key country dynamics
8.7.4.2. Competitive scenario
8.7.4.3. Regulatory framework
8.7.4.4. Reimbursement scenario
8.7.4.5. South Korea market estimates and forecasts, 2018 – 2030
8.7.5. Australia
8.7.5.1. Key country dynamics
8.7.5.2. Competitive scenario
8.7.5.3. Regulatory framework
8.7.5.4. Reimbursement scenario
8.7.5.5. Australia market estimates and forecasts, 2018 – 2030
8.7.6. Thailand
8.7.6.1. Key country dynamics
8.7.6.2. Competitive scenario
8.7.6.3. Regulatory framework
8.7.6.4. Reimbursement scenario
8.7.6.5. Thailand market estimates and forecasts, 2018 – 2030
8.8. Latin America
8.8.1. Brazil
8.8.1.1. Key country dynamics
8.8.1.2. Competitive scenario
8.8.1.3. Regulatory framework
8.8.1.4. Reimbursement scenario
8.8.1.5. Brazil market estimates and forecasts, 2018 – 2030
8.8.2. Mexico
8.8.2.1. Key country dynamics
8.8.2.2. Competitive scenario
8.8.2.3. Regulatory framework
8.8.2.4. Reimbursement scenario
8.8.2.5. Mexico market estimates and forecasts, 2018 – 2030
8.8.3. Argentina
8.8.3.1. Key country dynamics
8.8.3.2. Competitive scenario
8.8.3.3. Regulatory framework
8.8.3.4. Reimbursement scenario
8.8.3.5. Argentina market estimates and forecasts, 2018 – 2030
8.9. MEA
8.9.1. South Africa
8.9.1.1. Key country dynamics
8.9.1.2. Competitive scenario
8.9.1.3. Regulatory framework
8.9.1.4. Reimbursement scenario
8.9.1.5. South Africa market estimates and forecasts, 2018 – 2030
8.9.2. Saudi Arabia
8.9.2.1. Key country dynamics
8.9.2.2. Competitive scenario
8.9.2.3. Regulatory framework
8.9.2.4. Reimbursement scenario
8.9.2.5. Saudi Arabia market estimates and forecasts, 2018 – 2030
8.9.3. UAE
8.9.3.1. Key country dynamics
8.9.3.2. Competitive scenario
8.9.3.3. Regulatory framework
8.9.3.4. Reimbursement scenario
8.9.3.5. UAE market estimates and forecasts, 2018 – 2030
8.9.4. Kuwait
8.9.4.1. Key country dynamics
8.9.4.2. Competitive scenario
8.9.4.3. Regulatory framework
8.9.4.4. Reimbursement scenario
8.9.4.5. Kuwait market estimates and forecasts, 2018 – 2030
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.2.1. Innovators
9.3. Vendor Landscape
9.3.1. List of key distributors and channel partners
9.3.2. Key customers
9.3.3. Key company market share analysis
9.3.4. 3M
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Product benchmarking
9.3.4.4. Strategic initiatives
9.3.5. Hollister Incorporated
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Product benchmarking
9.3.5.4. Strategic initiatives
9.3.6. Cardinal Health
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Product benchmarking
9.3.6.4. Strategic initiatives
9.3.7. Integra LifeSciences Corporation
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Product benchmarking
9.3.7.4. Strategic initiatives
9.3.8. Coloplast Corp.
9.3.8.1. Company overview
9.3.8.2. Financial performance
9.3.8.3. Product benchmarking
9.3.8.4. Strategic initiatives
9.3.9. DeRoyal Industries, Inc.
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Product benchmarking
9.3.9.4. Strategic initiatives
9.3.10. Smith & Nephew
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Product benchmarking
9.3.10.4. Strategic initiatives
9.3.11. ConvaTec Inc.
9.3.11.1. Company overview
9.3.11.2. Financial performance
9.3.11.3. Product benchmarking
9.3.11.4. Strategic initiatives
9.3.12. Mölnlycke Health Care AB.
9.3.12.1. Company overview
9.3.12.2. Financial performance
9.3.12.3. Product benchmarking
9.3.12.4. Strategic initiatives
9.3.13. Johnson & Johnson
9.3.13.1. Company overview
9.3.13.2. Financial performance
9.3.13.3. Product benchmarking
9.3.13.4. Strategic initiatives
|
